| Skubitz, Amy Patrice |
University Of Minnesota
United States |
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection |
5R01CA262153-05 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |
| Slager, Susan L |
Mayo Clinic Rochester
United States |
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) |
4R01CA258465-04 |
|
Nicholas Hodges, Ph.D. |
| Smith, Jennifer Susan |
Univ Of North Carolina Chapel Hill
United States |
UNC CASCADE Network Research Base |
5UG1CA275403-04 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Sohl, Stephanie Jean |
Wake Forest University Health Sciences
United States |
REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) |
5R01CA266995-04 |
PAR-21-035 (R01 Clinical Trial Required) |
Goli Samimi, Ph.D., M.P.H. |
| Song, Ming |
University Of Louisville
United States |
Dietary fructose and NASH/HCC progression |
5R21CA290420-02 |
|
Amit Kumar, Ph.D. |
| Sorror, Mohamed |
Fred Hutchinson Cancer Center
United States |
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality |
5R01CA227092-06 |
|
Marjorie Perloff, M.D. |
| Spellman, Paul T. |
University Of California Los Angeles
United States |
Germline Determinants of Prostate Cancer Evolution |
5R01CA270108-03 |
|
Guillermo Marquez, Ph.D. |
| Spiegel, Brennan |
Cedars-Sinai Medical Center
United States |
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
5R01CA252211-05 |
|
Rachel Altshuler, Ph.D. |
| Stachler, Matthew D |
University Of California, San Francisco
United States |
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus |
3R37CA269649-04S1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Matthew Young, Ph.D. |
| Staff, Nathan P |
Mayo Clinic Rochester
United States |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
5R01CA275870-04 |
PAR-21-329 (R01 Clinical Trial Optional) |
Rachel Altshuler, Ph.D. |
